Objectives. To report the initial results of treatment of outlet obstruction induced by benign prostatic hy perplasia (BPH) using interstitial laser coagulation performed with the Indigo 830 nm diode laser system. Methods. A group of 112 men with lower urinary tract symptoms caused by BPH underwent treatment with the Indigo 830 nm laser system between October 1994 and November 1995. Patients were assessed prior to treatment and at specified post-treatment intervals for symptom score, uroflow, postvoid residual, and prostate volume. Adverse events and changes in laboratory parameters were monitored at each post-treatment visit to investigate safety of the procedure. Results. Symptom score decreased from 20.9 at initial measurement to 9,6 at 3 months after procedure and 7.9 at 6 months. Uroflow rate increased from 8.0 m i l s initially to 15.2 and 14.2 mL/s at 3 and 6 months, respectively. Residual bladder volumes decreased from 105 mL initially to 59 and 38 mL at 3 and 6 months, respectively. There were no major complications (impotence, sustained incontinence, significant blood loss). Minor complications occurred in a small number of patients but were generally associated with urinary tract infection in patients with catheters. Three patients (2.7%) required retreatment and underwent transurethral resection of the prostate. Conclusions. Interstitial laser coagulation using an 830-nm diode laser system appears to be a promising new treatment, with substantial improvements in objective and subjective parameters of obstruction and a favorable side-effect profile. UROLOGY 48: 223-228, 1996. 
T ransurethral resection of the prostate (TURP) is still the reference standard in the treatment of benign prostatic hyperplasia (BPH). The asso ciated problems and complications of TURP, such as significant bleeding, TUR syndrome, inconti nence, strictures, and sexual dysfunction are well known and have been described extensively.1"6 Despite general progress in medicine and postop erative care in recent years, the incidence of com plications following TURP remains virtually un-changed. With the rapidly aging population in the developed world, these complications are becom ing more significant. In addition, people today are more aware of surgical risks in general and, in creasingly, are demanding alternatives.
The treatment of BPH through interstitial laser coagulation (ILC) is a possible solution to this problem. In this treatment, prostatic tissue is heated from within the prostate to the point of irreversible necrosis. Unlike modalities that heat the prostate from the urethra, such as side-firing lasers, ILC does not require destruction of the ure thral epithelium. Healing occurs usually without sloughing of heated tissue because the urothelium . . . [8] [9] [10] remains intact.
Initial tests using interstitial laser devices were performed in vitro in different tissues and in vivo in the canine prostate. 7, 8, [11] [12] [13] The in vitro studies in muscle, liver, kidney, and the potato models showed that treatment volumes increased with la ser power and irradiation time unless charring oc-0090-4295/96/S15.00
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•êsëssr AUA score  89  91  87  91  81  74  54  68  Flow  92  89  87  77  73  69  56  66  Residual volume  70  70  70  70  69  70  61  61 months after treatment. These figures reflect im provement rates of 54% and 62% for the AUA score at 3 and 6 months, respectively, and 90% and 78% for the flow rate at the same respective inter vals. The post-void residual volume decreased from 105 (±75) mL prior to treatment to 59 (±85) mL and 38 (± 43) mL at 3 and 6 months, reflecting improvement rates of 44% and 64% at these intervals, respectively. All improvements were statistically significant, at P <0.001. The av erage catheterization time was 12.8 ( ± 7 .6 ) days, but this statistic was highly influenced by differing hospital policies. Many European hospitals have a standard policy of giving patients an outpatient ap pointment 14 days after their treatment to have a catheter removed regardless of the actual required catheterization time. Table I shows the percent ages of patients experiencing 0% to 10%, > 10% to 30%, >30% to 50%, and >50% improvement as measured by three parameters. There were no procedural complications. Oper ative and postoperative bleeding was insignificant. Thirty patients (27%) developed urinary tract in fections after the procedure. Twelve patients ( 1 1 %) experienced transient dysuria after treat ment, which in 9 cases was the result of a urinary tract infection. All patients were successfully treated with antibiotics. Retrograde ejaculation was reported in only 3 patients (2.7%). No im potence and no incontinence were reported.
FIGURE 6. O verall re su lts for 1 12 p a tie n ts a t initial tr e a tm e n t, 8 6 p a tie n ts a t 3 m o n th s, a n d 4 0 p a t ie n t s a t 6 m o n th s a fte r tre a tm e n t, w ith 8 3 0 -n m d io d e la s e r in terstitia l tr e a tm e n t o f BPH.

TABLE I. Patient improvement rates in AUA score, flow, and residual volume at follow-up of 3 and 6 months _______________________ Post-Treatment Improvement Rates (%)_______________________
0-10 >10-30 >30-50 >50 3 Months 6 Months 3 Months 6 Months 3 Months 6 Months 3 Months 6 Months
There were no late complications related to the procedure. Three patients (2.7%) with unsatisfac tory treatment results underwent subsequent TURP. Two of these men underwent TURP 3 to 6 months after ILC, and 1 had a TURP 7 months after the laser treatment.
COMMENT
During the recent past, several alternative treat ment modalities using laser energy for BPH have been described.17"24 The main reason for the de velopment and investigation of all these new tech niques has been to reduce the persistent compli cation rate of TURP. [4] [5] [6] 25, 26 In addition, some of the newer modalities were designed to treat the increasing number of high-risk patients.7,8 Al though all procedures claim to be minimally in vasive, the actual degree of invasiveness varies widely. Drug treatment is close to watchful wait ing,26 whereas contact laser vaporization21 and electrovaporization27,28 may be seen as modified TURPs that cause minimal bleeding.
Existing laser techniques for BPH treatment can be divided into three entirely different groups. Su perficial vaporization can be achieved using con tact or high-power noncontact techniques. il,2uy~33 Laser probes are used transurethrally to remove the periurethral tissue under direct vision, imme diately creating a TURP-like cavity. Finally, va porizing applicators can be used to do simple in cisions. 11 The most commonly used techniques employ sidefiring laser devices to achieve deep co agulation of the prostatic adenoma.17' 19,22,24,32^34 Applied transurethrally, usually under direct vi sion, these devices coagulate the periurethral tis sue, causing necrosis.11,33 During the weeks that follow, the necrotized tissue sloughs off, and a TURP-like cavity is formed.17 In contrast, in inter stitial laser coagulation the fiber is placed transur ethrally under direct vision inside the tissue. This creates large coagulated volumes without affecting the urethra. After treatment the resulting necrosis is gradually resorbed, with a subsequent shrinkage of the prostatic lobes. During this process, a wide TURP-like cavity is gradually formed, 9" 11 The treatments we have described vary greatly. Vaporizing techniques destroy the prostatic ure thra completely and remove the prostatic tissue by vaporization. This results in a situation highly comparable to that produced by a TURP. Vapori zation, however, reduces the occurrence of hem orrhage significantly. Sidefiring systems also de stroy the entire prostatic urethra because both the prostatic urethra and the underlying tissue are co agulated. The necrotized tissue sloughs off, some times causing significant irritation. Interstitial techniques preserve the prostatic urethra and co agulate the tissue inside the prostatic lobes. Be cause the prostatic urethra is still intact, symptoms of irritation are likely to be minimal Laser treatments using superficial vaporization can in theory treat any size prostate. However, in prostates with a volume above 60 g, treatment time is up to 50% longer than required for a TURP of a comparable gland.29 Sidefiring systems are rec ommended for treating prostates smaller than 60 grams.30 This is probably because even at high power, the laser light in these systems has limited penetration depth. 33 The amount of tissue that can be treated is limited because only the surface of the prostatic urethra can be irradiated, and deep coagulation of the lobes is difficult to attain. Thus the percentage of coagulated prostatic tissue de creases as the size of the prostate increases. Inter stitial laser systems can treat virtually all size pros tates because coagulation depends completely on the fiber placements. In large prostates, more and deeper punctures will be necessary, resulting in a larger coagulated volume than that following sidefire laser treatment. Treatment time is the only limiting factor. However, the time required is not excessive, as 4 minutes per puncture results in a coagulated volume of 5 to 6 cc.13
The side effects we found with interstitial laser coagulation were minimal, owing to the absence of tissue sloughing and the preservation of the prostatic urethra. The absence of retrograde ejac ulation can be explained by the fact that the blad der neck was not treated unless a median lobe was present. The retreatment rate of 2.7% within 6 months is considered acceptably low.
The complication rates found thus far in this study are very gratifying in contrast to the com plication rates often associated with TURP. 4"6,25,26 In spite of significant improvements in surgical technique, TURP still carries a small but signifi cant risk of major complications like impotence, sustained incontinence, and bleeding sufficient to require transfusions. None of those complications were observed in the present group. It must be kept in mind, however, that this group is too small to provide definitive data on the rates of these un common complications.
Our initial results, which represent the learningcurve treatments of six different centers, do pro vide substantial evidence that interstitial laser co agulation using an 830-nm diode laser system can improve both subjective complaints and objective parameters of BPH. All measured outcomes im proved significantly from preprocedure to 6month follow-up.
